Nicholas J. Mantis, Ph.D. [1]
Dr. Mantis’ research focuses on host-pathogen interactions and the development of vaccines for biodefense and emerging infectious diseases (BDEID). His primary interest is in the role of antibodies in conferring immunity to airborne, foodborne and vectorborne infections. The laboratory has ongoing collaborations with academic and biopharmaceutic partners to develop vaccines and monoclonal antibodies for human use against COVID-19, Lyme disease, pertussis, tetanus, Salmonella, cholera, and ricin toxin.
Dr. Mantis has received research awards from the:
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of Child Health and Human Development (NICHD)
- National Cancer Institute (NCI)
- National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Department of Defense (DOD)
- Bill and Melinda Gates Foundation (BMGF).